and joined the MJH Life Sciences team in April 2021. She graduated from Kent State University in 2018 with a bachelor's degree in journalism and a minor in sociology. Linda used to work as a creative writer for 

 and was a technical writer/regulatory specialist/purchasing agent at GM Industrial before coming on to the team. She enjoys reading, traveling, and learning new perspectives. You can reach her at 

Articles

The National Psoriasis Foundation has released new guidance statements after the Centers for Disease Control and Prevention provided new information on COVID-19 vaccine boosters for immunocompromised patients. 

NPF Releases COVID-19 Booster Guidance

A recently published study compared cognition, MRI-markers, and dementia risk in patients diagnosed with psoriasis vs those without psoriasis.  

Link Between Psoriasis and Dementia Investigated

Lack of specific phenotypes complicates verification.

Find the Difference: Drug-Related Psoriasis

Lisette Hilton is a writer in Boca Raton, Fla., who heads up her company, Words Come Alive.

According to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations. 

French Results Echo Expert Findings

Morgan Petronelli is an associate editor for 

and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining 

She enjoys working out, listening to music, and playing with her dog Scout. You can reach her at 

Podcasts

Mark Lebwohl, MD, takes a deep dive in the recent delay in approval for multiple JAK inhibitor drugs for treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis. He also discusses the impact of the delay, as well as the benefits of JAK inhibitors for inflammatory skin diseases, and an outlook for the future of this drug class.

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

The FDA is now requiring black box warning for certain JAK inhibitors used to treat arthritis. This news comes amid delay in FDA approval for multiple JAK inhibitors for the treatment of inflammatory skin conditions.  

FDA Requiring Black Box Warning for Certain JAK Inhibitors  

Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.

Some systemic medications may have increased risk for patients during the COVID-19 era, according to a recent Pediatric Dermatology Research Alliance (PeDRA) statement.

PeDRA Lists Systemics With Higher COVID-19 Risk

Theresa Vavra, PharmD, BCPS, provides studies for some of the most commonly used supplements by patients with psoriasis.

Studies of Commonly Used Supplements for Psoriasis

Whitney Linsenmeyer, PhD, RD, LD, provides 3 dietary considerations for patients with psoriasis.

 3 Dietary Considerations for Psoriasis 

COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis. 